Cardinal Health Q1 revenue rises 22% to $64 billion; raises fiscal 2026 EPS guidance
Cardinal Health reported first-quarter fiscal 2026 revenue of $64 billion, up 22% from a year earlier, with GAAP diluted EPS up 11% to $1.88 and non-GAAP diluted EPS up 36% to $2.55. The company raised its fiscal 2026 non-GAAP EPS guidance to $9.65 to $9.85 from $9.30 to $9.50, and expects to complete the Solaris Health acquisition in early November, which will bring higher interest expense.
Key points
- GAAP diluted EPS rose 11% to $1.88; non-GAAP diluted EPS rose 36% to $2.55 in the quarter ended September 30, 2025.
- Fiscal 2026 non-GAAP EPS guidance raised to $9.65 to $9.85 from $9.30 to $9.50; adjusted free cash flow outlook raised to $3.0 billion to $3.5 billion.
- Interest and other expense outlook raised to about $325 million from about $275 million, reflecting financing costs for the Solaris Health acquisition.
- A $375 million accelerated share repurchase program was initiated in the first quarter.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.